Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$0.15 - $0.37 $283,007 - $698,084
1,886,715 New
1,886,715 $301,000
Q2 2018

Aug 13, 2018

SELL
$0.42 - $0.74 $168,346 - $296,611
-400,826 Closed
0 $0
Q4 2017

Jan 31, 2018

SELL
$1.1 - $1.54 $440,908 - $617,272
-400,826 Reduced 50.0%
400,826 $465,000
Q3 2017

Nov 09, 2017

BUY
$1.19 - $1.43 $953,965 - $1.15 Million
801,652
801,652 $1.06 Million

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Alliance Wealth Management Group Portfolio

Follow Alliance Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliance Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Alliance Wealth Management Group with notifications on news.